Veraxa Biotech AG - Post de-SPAC

VRXA

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0002079109

SEC filings (opens in a new tab)

In the last 90 days, Veraxa Biotech AG - Post de-SPAC insiders filed 2 open-market purchases and 0 sales; 8 institutions reported holding it in 13F filings for Q2 2026, worth $599.6K in total; no superinvestor holds it.

Other share classesVRXAW

Superinvestors holding VRXA, Q2 2026

See all superinvestors

No superinvestor reported holding VRXA in Q2 2026.